CD20 monoclonal antibody（The First Affiliated Hospital of Soochow University）

N/A

Report date: 2022/11/20 14:57:00

Base Information

Drug NameCD20 monoclonal antibody（The First Affiliated Hospital of Soochow University）
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-CD20
TargetsB-lymphocyte antigen CD20
Therapy Area/IndicationsAnemia, Aplastic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesThe First Affiliated Hospital Of Soochow University
China Registration ClassN/A

Develop Information

Active CompaniesThe First Affiliated Hospital Of Soochow University
Inactive CompaniesN/A
Active IndicationsAnemia, Aplastic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A